Abstract
Patients with multiple myeloma are often treated surgically as though they have bone metastases. Due to major differences in oncological therapy and comparatively long survival times these patients should be considered separately. Seventy-five multiple myeloma patients were treated surgically (83 interventions) for skeletal complications of the disease. Location and dissemination, symptoms, method of surgery, complications, recurrence and survival time were evaluated retrospectively. Most of the lesions were in the axial skeleton or the proximal extremities apart from one distal lesion of the fibula, and most surgery was performed in the spine (35 patients). The mean follow-up of patients was 5.4 years (range 1–25 years). Survival proved to be very favourable (37% at five years). Patients with a single bone lesion, a negative bone marrow biopsy, no paraproteinaemia in serum or a Salmon-Durie-stage I had a better survival probability. Surgical treatment in patients with multiple myeloma was mostly limited to a palliative approach but survival time was better (37% at five years) than in patients with metastatic bone disease which has to be considered in their surgical treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mundy GR, Bertolini DR (1986) Bone destruction and hypercalcemia in plasma cell myeloma. Semin Oncol 13:291–299
Kyle RA (1975) Multiple myeloma: review of 869 cases. Mayo Clin Proc 50:29–40
Bataille R, Sany J (1981) Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer 48:845–851
Chak LY, Cox RS, Bostwick DG, Hoppe RT (1987) Solitary plasmacytoma of bone: treatment, progression, and survival. J Clin Oncol 5:1811–1815
Zahlten-Hinguranage A, Goldschmidt H, Cremer FW, Egerer G, Moehler T, Witte D et al (2006) Preoperative elevation of serum C-reactive protein is predictive for prognosis in myeloma bone disease after surgery. Br J Cancer 95:782–787
Jonsson B, Sjostrom L, Jonsson H Jr, Karlstrom G (1992) Surgery for multiple myeloma of the spine. A retrospective analysis of 12 patients. Acta Orthop Scand 63:192–194
McLain RF, Weinstein JN (1989) Solitary plasmacytomas of the spine: a review of 84 cases. J Spinal Disord 2:69–74
Saad F, Lipton A, Cook R, Chen YM, Smith M, Coleman R (2007) Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer 110:1860–1867
Durr HR, Kuhne JH, Hagena FW, Moser T, Refior HJ (1997) Surgical treatment for myeloma of the bone. A retrospective analysis of 22 cases. Arch Orthop Trauma Surg 116:463–469
Muhlbauer M, Pfisterer W, Eyb R, Knosp E (2000) Noncontiguous spinal metastases and plasmocytomas should be operated on through a single posterior midline approach, and circumferential decompression should be performed with individualized reconstruction. Acta Neurochir (Wien) 142:1219–1230
Vieweg U, Meyer B, Schramm J (2001) Tumour surgery of the upper cervical spine—a retrospective study of 13 cases. Acta Neurochir (Wien) 143:217–225
Wangsaturaka P, Asavamongkolkul A, Waikakul S, Phimolsarnti R (2007) The results of surgical management of bone metastasis involving the periacetabular area: Siriraj experience. J Med Assoc Thai 90:1006–1013
Kunisada T, Choong PF (2000) Major reconstruction for periacetabular metastasis: early complications and outcome following surgical treatment in 40 hips. Acta Orthop Scand 71:585–590
Hentschel SJ, Burton AW, Fourney DR, Rhines LD, Mendel E (2005) Percutaneous vertebroplasty and kyphoplasty performed at a cancer center: refuting proposed contraindications. J Neurosurg Spine 2:436–440
Yeh HS, Berenson JR (2006) Treatment for myeloma bone disease. Clin Cancer Res 12:6279s–6284s
Levy V, Katsahian S, Fermand JP, Mary JY, Chevret S (2005) A meta-analysis on data from 575 patients with multiple myeloma randomly assigned to either high-dose therapy or conventional therapy. Medicine (Baltimore) 84:250–260
Segeren CM, Sonneveld P, van der Holt B, Vellenga E, Croockewit AJ, Verhoef GE et al (2003) Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study. Blood 101:2144–2151
van de Velde HJ, Liu X, Chen G, Cakana A, Deraedt W, Bayssas M (2007) Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma. Haematologica 2007(92):1399–1406
Barlogie B (1995) Plasma cell myeloma. In: Williams WJ, Beutler E (eds) Hematology, 5th edn. McGraw-Hill-Publishing Co., New York, pp 1109–1126
Pasqualetti P, Casale R, Collacciani A, Colantonio D (1991) Prognostic factors in multiple myeloma: a new staging system based on clinical and morphological features. Eur J Cancer 27:1123–1126
Utzschneider S, Weber P, Fottner A, Wegener B, Jansson V, Durr HR (2009) Prognosis-adapted surgical management of bone metastases. Orthopade 38:308–315
Durr HR, Wegener B, Krodel A, Muller PE, Jansson V, Refior HJ (2002) Multiple myeloma: surgery of the spine: retrospective analysis of 27 patients. Spine 27:320–324
Lecouvet FE, Vande Berg BC, Maldague BE, Michaux L, Laterre E, Michaux JL et al (1997) Vertebral compression fractures in multiple myeloma. Part I. Distribution and appearance at MR imaging. Radiology 204:195–199
Acknowledgements
No benefits or funds were received in support of the study.
Conflict of interest statement
All authors disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Utzschneider, S., Schmidt, H., Weber, P. et al. Surgical therapy of skeletal complications in multiple myeloma. International Orthopaedics (SICOT) 35, 1209–1213 (2011). https://doi.org/10.1007/s00264-010-1127-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-010-1127-0